Related Experiment Video

Updated: May 19, 2026

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
07:52

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

The fibrillin-1 gene: unlocking new therapeutic pathways in cardiovascular disease

Paddy M Barrett1, Eric J Topol

  • 1Scripps Translational Science Institute, 3344 N Torrey Pines Court Suite 300, La Jolla, CA 92037, USA.

Heart (British Cardiac Society)
|September 4, 2012
PubMed

Insights

Genetic testing for FBN-1 mutations can identify individuals at increased risk for aortic disease. Early detection of FBN-1 mutations enables proactive cardiovascular monitoring and interventions.

Area of Science:

  • Genomics
  • Cardiovascular Medicine
  • Genetic Pathology

Background:

  • Advances in DNA sequencing reveal genomic alterations linked to polygenic cardiovascular diseases.
  • Abnormalities of the proximal aorta were previously considered solely related to Marfan syndrome or aortopathy.
  • FBN-1 mutations are now recognized as independent risk factors for cardiovascular complications.

Purpose of the Study:

  • To explore the role of FBN-1 gene mutations in proximal aortic abnormalities.
  • To highlight the cardiovascular risks associated with FBN-1 mutations beyond Marfan syndrome.
  • To emphasize the importance of genetic awareness for early intervention in aortic disease.

Main Methods:

  • Genomic sequencing to identify FBN-1 mutations.
  • Clinical evaluation of cardiovascular phenotypes in affected individuals.
  • Review of existing literature on FBN-1 mutations and aortopathy.

Main Results:

  • FBN-1 mutations independently increase cardiovascular complication risk.
  • Angiotensin receptor blockers show promise in reducing aortic root dilatation.
  • Awareness of FBN-1 mutations necessitates vigilance for cardiovascular phenotypes.

Conclusions:

  • FBN-1 gene mutations are significant contributors to proximal aortic disease and associated cardiovascular risks.
  • Identifying FBN-1 mutations allows for earlier, targeted interventions and monitoring.
  • Genetic insights into FBN-1 mutations can guide proactive management of aortic conditions.

More Related Videos

Isolation and Characterization of Adult Cardiac Fibroblasts and Myofibroblasts10:45

Isolation and Characterization of Adult Cardiac Fibroblasts and Myofibroblasts

Published on: March 12, 2020

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...